BridgeBio Pharma (BBIO)

BridgeBio Pharma (BBIO) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• BBIO last traded at $75.72, 1.03% on the day.
• BridgeBio Pharma: market cap $14.60B, P/E -24.9, revenue $945.54M over the last four quarters.
• Over the past year BBIO returned 19.49%; year to date -1.01%.

Updated 2026-11-02 17:51 UTC